scispace - formally typeset
D

Don O. Kikkawa

Researcher at University of California, San Diego

Publications -  208
Citations -  3241

Don O. Kikkawa is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Eyelid & Medicine. The author has an hindex of 28, co-authored 183 publications receiving 2636 citations. Previous affiliations of Don O. Kikkawa include Jules Stein Eye Institute & University of Wisconsin-Madison.

Papers
More filters
Journal ArticleDOI

Stimulation of noradrenergic sympathetic outflow by calcitonin gene-related peptide.

TL;DR: It is reported here that CGRP acts in the central nervous system to stimulate selectively noradrenergic sympathetic outflow and is identified immunocytochemically throughout the central and peripheral nervous systems.
Journal ArticleDOI

Relations of the superficial musculoaponeurotic system to the orbit and characterization of the orbitomalar ligament.

TL;DR: The SMAS was found to be intimately related to the eyelids and orbicularis oculi muscle, and to have distinct orbital bony attachments, which have implications not only in cosmetic surgery but also in the understanding of facial soft tissue changes that occur with aging.
Journal ArticleDOI

Graded orbital decompression based on severity of proptosis.

TL;DR: Graded orbital decompression based on the severity of preoperative exophthalmometry is useful to determine the type and amount of orbital surgery to be performed.
Journal ArticleDOI

Natural killer/T-cell lymphoma with ocular and adnexal involvement.

TL;DR: The large cohort reported to date, demonstrates the high lethality of this condition despite aggressive conventional therapy, suggesting that new treatment options should be considered early in the course of treatment of patients with this disorder.
Journal ArticleDOI

Psychological disturbance in graves ophthalmopathy.

TL;DR: Patients with moderate to severe Graves ophthalmopathy have significant mood disturbance, especially when disfiguring signs are predominant, and evaluation of the psychological burden of the disease should be considered in routine follow-up and in decisions regarding treatment.